These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2005-004599-19||INTERFANT 06||2010-02-10||bad-data|
|Completed, but no date||2006-005077-21||A Phase II study of concurrent radiation and Temozolomide followed by Temozolomide and Lomustine (CCNU) in the treatment of Children with High Grade Glioma||bad-data|
|Ongoing||2011-006239-44||An international collaborative study to discontinue Imatinib/Glivec® in pediatric CML patients with sustained complete molecular response||not-yet-due|
|Ongoing||2012-000067-25||Protocol ALL-11: Treatment study protocol of the Dutch Childhood Oncology Group for children and adolescents (1-19 year) with newly diagnosed acute lymphoblastic leukemia||not-yet-due|
|Not reported Terminated||2014-003303-30||TropicALL study; Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a randomized controlled trial||2018-12-20||due-trials|